Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

New Therapy Improves Cognition in Down Syndrome Patients

Summary by Ground News
Pulsatile GnRH therapy improves cognitive function and neural connectivity in a small patient group. Seven men with Down syndrome, between 20 and 50 years of age, received one subcutaneous dose of GnRH every two hours for 6 months via a pump placed on the arm. Cognition and olfactory tests as well as MRI exams were performed before and after treatment.

1 Articles

Sci Tech DailySci Tech Daily
Center

New Therapy Improves Cognition in Down Syndrome Patients

A new treatment has been shown to improve cognitive function. In order to enhance the cognitive abilities of a small sample of Down syndrome patients, an Inserm team at the Lille Neuroscience & Cognition laboratory (Inserm/Université de Lille, Lille University Hospital) has collaborated with t

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Sci Tech Daily broke the news in on Saturday, October 1, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Technology icon

Technology

Science icon

Science

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal